Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort

被引：0
作者：
Corentin Le Cacheux
Audrey Couturier
Clara Sortais
Roch Houot
Morgane Péré
Thomas Gastinne
Amélie Seguin
Jean Reignier
Jean-Baptiste Lascarrou
Jean-Marc Tadié
Quentin Quelven
Emmanuel Canet
机构：
[1] Centre Hospitalier Universitaire Hôtel-Dieu,Service de Médecine Intensive Réanimation
[2] Rennes University Hospital,Clinical Haematology Department
[3] Rennes University,Haematology Department
[4] Nantes University Hospital,Biostatistics Department
[5] Nantes University,ICU
[6] Nantes University Hospital,ICU
[7] Nantes University,undefined
[8] Nantes University,undefined
[9] Nantes University Hospital,undefined
[10] —Interactions—Performance Research Unit (MIP,undefined
[11] UR 4334),undefined
[12] Rennes University Hospital,undefined
[13] Rennes University,undefined
来源：
Annals of Intensive Care | / 14卷
关键词：
Chimeric antigen receptor T Cell; Intensive care unit; Cytokine release syndrome; Immune effector cell-associated neurotoxicity syndrome; Haemophagocytic lymphohistiocytosis; Sepsis; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 193 条
[11]  
Waller EK(2018)Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy Br J Haematol 183 364-374
[12]  
Borchmann P(2018)Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia Cancer Discov 8 958-971
[13]  
McGuirk JP(2020)Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US lymphoma CAR T consortium J Clin Oncol Off J Am Soc Clin Oncol 38 3119-3128
[14]  
Neelapu SS(2018)Chimeric antigen receptor therapy N Engl J Med 379 64-73
[15]  
Locke FL(2018)Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy Blood 131 121-130
[16]  
Bartlett NL(2019)Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data Intensive Care Med 45 977-987
[17]  
Lekakis LJ(2021)Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study Lancet Haematol 8 e355-e364
[18]  
Miklos DB(2022)Critically ill patients treated for chimeric antigen receptor-related toxicity: a multicenter study Crit Care Med 50 81-92
[19]  
Jacobson CA(2022)The use of ICU resources in CAR-T cell recipients: a hospital-wide study Ann Intensive Care 12 75-808
[20]  
Maude SL(2007)Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies BMJ 335 806-638
12345678910